Skip to main content

Antoine Lacombe

Research assistant Aix-Marseille UniversitéFaculté d'économie et de gestion (FEG)

Lacombe
PhD
An understanding of willingness to test for several diseases using behavioral economics tools
Since 2022, under the direction of Sylvie Boyer, Bruno Ventelou
Download
CV
Address

AMU - AMSE
5-9 Boulevard Maurice Bourdet, CS 50498
​13205 Marseille Cedex 1

Abstract This study examines the acceptance of artificial intelligence (AI)-based diagnostic alternatives compared to traditional biological testing through a randomized scenario experiment in the domain of neurodegenerative diseases (NDs). A total of 3225 pairwise choices of ND risk-prediction tools were offered to participants, with 1482 choices comparing AI with the biological saliva test and 1743 comparing AI+ with the saliva test (with AI+ using digital consumer data, in addition to electronic medical data). Overall, only 36.68% of responses showed preferences for AI/AI+ alternatives. Stratified by AI sensitivity levels, acceptance rates for AI/AI+ were 35.04% at 60% sensitivity and 31.63% at 70% sensitivity, and increased markedly to 48.68% at 95% sensitivity (p
Keywords Artificial intelligence, AI diagnostics, Neurodegenerative diseases, Machine learning